Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the effects (good and bad) of
supplementation with Glutamine to that of a placebo (L-alanine), on your child and their
Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to
oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections,
improving growth, and/or changing the make-up of bacteria in your child's intestine.
Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study,
the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in
children.
Phase:
N/A
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborators:
Emmaus Medical, Inc. Emory University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) University of Colorado, Denver University of Michigan